Dystonia with marked diurnal variation associated with biopterin deficiency.
Two pairs of siblings with severe dystonia with marked diurnal fluctuation had both reduced CSF concentration of biopterin and marked symptomatic improvement of the dystonia in response to levodopa. Whether the reduced concentration of biopterin reflects focal abiotrophy of biopterin-containing neurons or deficiency of biopterin synthesis is uncertain. A fifth individual, who had a systemic deficiency of biopterin synthesis, shared the features of reduced biopterin in CSF, marked diurnal variation in the degree of dystonia, and clinical improvement in response to levodopa. Generalized dystonia with marked diurnal fluctuation was therefore shared by the four patients in whom biopterin deficiency was limited to the CNS and the patient with systemic deficiency of biopterin.
D000293:Adolescent; D000328:Adult; D001708:Biopterins / Q000031:analogs & derivatives / Q000134:cerebrospinal fluid / Q000172:deficiency*; D002230:Carbidopa / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002940:Circadian Rhythm; D004338:Drug Combinations / Q000627:therapeutic use; D004421:Dystonia / Q000150:complications* / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D005260:Female; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D019798:Neopterin; D012801:Sibling Relations
D004338:Drug Combinations; C009265:carbidopa, levodopa drug combination; D001708:Biopterins; D007980:Levodopa; D006897:Hydroxyindoleacetic Acid; D019798:Neopterin; D002230:Carbidopa; D006719:Homovanillic Acid